Autoantibodies against double-stranded DNA (dsDNA) were first described> 60 years ago
and although they are still one of the most clinically relevant autoantibodies, test results may …

Background Autoantibody specificity in autoimmune diseases is variable due to each
patient's individual spectrum of autoantibodies and the inherent differences between …

Objective: The effectiveness and safety of belimumab in Chinese lupus patients with
different disease activities were investigated in a real-world setting. Method: Patients who …

Anti–double‐stranded DNA antibodies (anti‐dsDNA) are considered a specific marker for
systemic lupus erythematosus (SLE). Though the Farr technique was once the reference …

Antibodies to dsDNA are an important laboratory parameter for diagnosis, monitoring and
classification of systemic lupus erythematosus (SLE). In clinical laboratories, several …

Objective Elevated double-stranded DNA (dsDNA) antibody levels in blood serum are
considered a disease-specific marker in systemic lupus erythematosus (SLE), correlate with …

Background This study evaluated the diagnostic performances of total and high-avidity (HA)
anti-dsDNA enzyme immunoassays (EIA) in Chinese systemic lupus erythematosus (SLE) …

Objectives Detection of antinuclear antibodies (ANA) by immunofluorescence assay (IFA) is
increasingly substituted by multiplex bead-based immunoassay (MBA) and line-blot …

Systemic lupus erythematosus (SLE) is a common autoimmune disease, which features the
secretion of antibodies directed against autoantigens in vivo. In the present study, a peptide …

Objectives Detection of specific antinuclear antibodies is very important in term of diagnosis,
prognosis and management of patients with systemic autoimmune rheumatic diseases …